Biotech Stocks

Spooked Investors Send Trevena (TVRN) Stock Spiraling as the Company’s Lead Drug Candidate Faces Major Downfall

The US Food and Drug Administration (FDA) puts the needle in the arm of drug company Trevena (TRVN). The agency’s critical briefing documents …

Amarin (AMRN) Stock Gaining as This Analyst Doubles Price Target

Can you feel the ground moving beneath your feet? Amarin (AMRN) share price has jumped nearly seven-folds in value over the past 2 …

Here’s Why Amedica (AMDA) Stock Skyrocketed Today

Amedica’s (AMDA) long-suffering bulls finally have reason to celebrate: The medical device maker announced closing of the sale of its spinal implant franchise …

Tilray (TLRY) CBD 100 Will Be Supplied to Additional Pediatric Patients in Australia; Shares Up 7% AH

Tilray (TLRY) announced this afternoon that it has successfully exported medical cannabis from Canada to Australia to distribute to critically ill children. Tilray shares …

Here’s Why Teva Pharmaceutical (TEVA) Stock Soared Today

There’s a new FDA-approved migraine treatment on the scene. On Friday night, the U.

Here’s Why Arrowhead (ARWR) Skyrocketed Over 50% Today

Investors love biotech stocks for the lottery ticket-like returns they can offer if a company strikes medical gold. Case in point: Arrowhead (NASDAQ:ARWR), …

Here’s Why Sophiris (SPHS) Stock Skyrockets Today

Sophiris (NASDAQ:SPHS) shares are shooting up 27% faster than Jack’s magic bean sparking right into a giant beanstalk. The reason?

Adamis Pharmaceuticals (ADMP) Provides a Business Update After Rollercoaster Month for the Stock

Adamis Pharmaceuticals (NASDAQ:ADMP) shares tumbled as much as 30% this month, prompting plenty of inquiries from investors. Dr.

Here’s Why Pain Therapeutics (PTIE) Stock Crashed Today

The past two months turned out to be a nightmare for shareholders of Pain Therapeutics (NASDAQ:PTIE). Shares have fallen nearly 81% after the FDA rejected …